Navigation Links
Off-label morning sickness drug deemed safe for fetuses -- Ben-Gurion U. researchers
Date:6/10/2009

BEER-SHEVA, ISRAEL, June 10, 2009 Metoclopramide, a drug approved in the U.S. for nausea, vomiting and heartburn poses no significant risks for the fetus according to a large cohort study published in the June 11 issue of the prestigious New England Journal of Medicine, "The Safety of Metoclopramide Use in the First Trimester of Pregnancy" (N Engl J Med 2009;360:24 June 11, 2009).

According to the pediatrician and clinical pharmacologist, principal investigator Dr. Rafael Gorodischer, prof. emeritus at Ben-Gurion University of the Negev, "Metoclopramide is the drug of choice in Europe and Israel for "morning sickness-like" symptoms of nausea and vomiting, which are common in pregnant women. In the U.S. however, it is only used in the most severe cases, as it is an "off-label" use for nausea and vomiting during pregnancy. The findings of this very large cohort study examining infants born to mothers who were exposed to metoclopramide during the first trimester provide significant reassurance for the safety of the fetus when the drug is given to women to relieve nausea and vomiting during pregnancy."

Between 50 percent to 80 percent of pregnant women experience nausea and vomiting during the first trimester and beyond, which can be severe.

This study is collaboration between Ben-Gurion University of the Negev, Soroka University Medical Center and Clalit Health Services -- all in Beer-Sheva, Israel -- along with the Division of Pharmacology, Hospital for Sick Children in Toronto, Canada. The study is part of the doctoral thesis of Ilan Matok and was conducted by the three Israeli entities as part of the BeMORE collaboration (Ben-Gurion MotheRisk Obstetric Registry of Exposure). The study of the safety of other medications commonly used off-label in pregnancy is an ongoing project of BeMORE investigators in large cohorts of women in Southern Israel.

According to principal investigator epidemiologist Dr. Amalia
'/>"/>

Contact: Andrew Lavin
alc@alavin.com
516-353-2505
American Associates, Ben-Gurion University of the Negev
Source:Eurekalert

Page: 1 2

Related medicine news :

1. IROs Help Decide Medically on Approved Uses of Off-Label Drugs for Cancer
2. Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices
3. Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa
4. Medtronic, Inc. and Medtronic Sofamor Danek USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) Bone Graft Product, According to Page Perry, LLC
5. Medtronic, Inc. and Medtronic Sofamor Danek, USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) Bone Graft Product, According to Page Perry, LLC
6. Study Calls for Greater Scrutiny of Off-Label Drug Use
7. Most Off-Label Cancer Drug Use for Palliative Care
8. Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
9. Abortion drugs off-label use may have led to deaths
10. Off-Label Drug Use Needs Strong Oversight
11. Otsuka to Pay More Than $4 Million to Resolve Off-Label Marketing Allegations Involving Abilify
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 04, 2015 The ability of ... density assessment and help improve breast cancer risk ... accepted for presentation at the European Congress of ... abstracts - eight posters and 2 session presentations ... breast density and quantitative breast imaging software tools ...
(Date:3/4/2015)... With the growing influence of movies, television, video games and ... adults, combined with the increasingly frantic lifestyle of modern parents, ... up with what kids are into these days. It seems ... daily basis. , The same is also true for drugs ... to discreetly talk about them, are constantly changing. These tips ...
(Date:3/4/2015)... York, New York (PRWEB) March 04, 2015 ... was reviewing the cardiovascular risks potentially associated with low ... Drug Administration (FDA) announced that it will now require ... may increase their risk for heart attacks and strokes. ... 3, 2015, the agency also stated that it was ...
(Date:3/4/2015)... Vancouver, BC (PRWEB) March 04, 2015 ... Center, has recently received two awards in the ... Choice Awards on February 27, 2015. The company ... and second place in the “Best Registered Massage ... largest distributed community newspapers in Canada, The Vancouver ...
(Date:3/4/2015)... New York, NY (PRWEB) March 04, 2015 ... within the centerfold of The San Francisco Chronicle with ... readership of 500,000 readers. Its digital component is distributed ... a network of top news sites and partner outlets. ... click here. , Milorganite is composed of ...
Breaking Medicine News(10 mins):Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 5Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4Health News:Backs in Action Receives Two Awards in The Vancouver Courier Readers’ Choice Awards 2015 2
... Johnson Institute has transferred key programs and products ... under an agreement reached last week by the ... transfer ensures a continuation of the Johnson Institute,s ... possibility of recovery from alcoholism and dependence on ...
... March 4 Scanning the CDC website can be ... CDC concedes that over two million patients will acquire ... as 100,000 will die as a result. CDC studies ... risks and add 9 additional days to a hospital ...
... March 4 Fingertip Formulary, the leading provider ... data, introduces one-click access to customized formulary data ... web-based formulary reporting platform, now offers subscribers the ... access. The analytics platform offers eleven comprehensive reports ...
... China, March 4 /PRNewswire-Asia-FirstCall/ -- China Shenghuo,Pharmaceutical ... Shenghuo" or,the "Company"), today announced the expansion ... with the Company,s business outlook, to optimize ... Company expanded the number,of senior management personnel ...
... The Quantum Group, Inc. (NYSE Amex: ... Organization (HSO), announced today that Quantum subsidiary Renaissance ... a Strategic Alliance Agreement with Pro Med Healthcare ... offer staffing services to the 2,000 healthcare providers ...
... Elsevier,world-leading publisher of scientific, technical and medical information,products ... 2009 launch of a new,peer-reviewed medical journal in ... (ACOFP), Osteopathic Family Physician. , ... American College of,Osteopathic Family Physicians, is designed to ...
Cached Medicine News:Health News:Johnson Institute Transfers Key Programs and Products to Hazelden Foundation 2Health News:Mercy Hospital at Folsom Acquires Advanced Germicidal Technology to Battle MRSA, C. diff, Acinetobacter and Other Drug-Resistant Pathogens 2Health News:Fingertip Formulary Analytics(R) Offers One-Click Access to Customized Formulary Data and Co-Pay Reports 2Health News:China Shenghuo Announces Management Expansion and Enhanced Internal Controls 2Health News:China Shenghuo Announces Management Expansion and Enhanced Internal Controls 3Health News:China Shenghuo Announces Management Expansion and Enhanced Internal Controls 4Health News:Renaissance Health Systems Establishes Strategic Alliance for Staffing Solutions to Healthcare Providers 2Health News:Renaissance Health Systems Establishes Strategic Alliance for Staffing Solutions to Healthcare Providers 3Health News:Renaissance Health Systems Establishes Strategic Alliance for Staffing Solutions to Healthcare Providers 4Health News:Elsevier Announces Launch of Osteopathic Family Physician Publishing Partnership Formed With American College of Osteopathic Family Physicians 2Health News:Elsevier Announces Launch of Osteopathic Family Physician Publishing Partnership Formed With American College of Osteopathic Family Physicians 3
(Date:3/4/2015)... 4, 2015 Alimera Sciences, Inc. (NASDAQ: ... that specializes in the research, development and commercialization ... for the fourth quarter and year ended December ... a pivotal year for Alimera Sciences, most notably ... September for the treatment of diabetic macular edema," ...
(Date:3/4/2015)... , March 4, 2015 Acsis Inc., ... and serialization solutions, announced it will be hosting a ... The live event, "How to Boost Manufacturing Efficiency and ... March 18th at 2:00 PM EDT.  ... Acsis, and John Gordon , Chief Information Officer ...
(Date:3/4/2015)... ROCHESTER, Minn. , March 4, 2015   ... reached an agreement to develop the next generation of ... "We are hoping that this technology will be ... obesity and diabetes," says James Levine, M.D., Ph.D. ... researcher. "They are accurate, inexpensive, and can be integrated ...
Breaking Medicine Technology:Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 2Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 3Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 4Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 5Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 6Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 7Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 8Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 9Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 10Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 11Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 12Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 13Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 14Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3
... HAYWARD, Calif., Aug. 11, 2011 While media worldwide ... of  food-borne bacterial epidemics, a new USDA study finds ... its toxins--at the center of many of today,s most ... ground-breaking research conducted at the Albany, California, Western Regional ...
... WILLOWICK, Ohio, Aug. 11, 2011 Time is money, and time ... throwing money away. A first-of-its-kind mobile and HTML5 app ... and medical professionals save both time and money. With just a ... to a list of the optimum ultrasound machines based on their ...
Cached Medicine Technology:Scientists at USDA Says CREAGRI HIDROX® Effective Against Staphylococcus aureus Bacteria and Staphylococcus Enterotoxin A 2Providian Medical Launches New Tool to Make Finding the Right Ultrasound Machine Easier Than Ever 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: